Literature DB >> 33979207

Reply to H. Shojima et al.

Kate Absolom1, Lorraine Warrington1, Eleanor Hudson1, Jenny Hewison1, Patricia Holch1, Bryony Dawkins1, Claire Hulme1, Julia Brown1, Galina Velikova1.   

Abstract

Entities:  

Year:  2021        PMID： 33979207      PMCID： PMC8331061          DOI： 10.1200/JCO.21.00684

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  8 in total

1.  How Can We Evaluate the Electronic Patient-Reported Outcome Appropriately?

Authors:  Hikaru Shojima; Akihiko Shimomura; Midori Kadowaki; Yukino Kawamura; Chikako Shimizu
Journal:  J Clin Oncol       Date:  2021-05-12       Impact factor: 44.544

2.  Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.

Authors:  Kate Absolom; Lorraine Warrington; Eleanor Hudson; Jenny Hewison; Carolyn Morris; Patricia Holch; Robert Carter; Andrea Gibson; Marie Holmes; Beverly Clayton; Zoe Rogers; Lucy McParland; Mark Conner; Liz Glidewell; Barbara Woroncow; Bryony Dawkins; Sarah Dickinson; Claire Hulme; Julia Brown; Galina Velikova
Journal:  J Clin Oncol       Date:  2021-01-08       Impact factor: 44.544

3.  Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients.

Authors:  Patricia Holch; Lorraine Warrington; Barbara Potrata; Lucy Ziegler; Ceri Hector; Ada Keding; Clare Harley; Kate Absolom; Carolyn Morris; Leon Bamforth; Galina Velikova
Journal:  Acta Oncol       Date:  2016-08-23       Impact factor: 4.089

4.  Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).

Authors:  Kate Absolom; Andrea Gibson; Galina Velikova
Journal:  Med Care       Date:  2019-05       Impact factor: 2.983

5.  The applications of PROs in clinical practice: what are they, do they work, and why?

Authors:  Joanne Greenhalgh
Journal:  Qual Life Res       Date:  2008-12-23       Impact factor: 4.147

Review 6.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Authors:  Bryce B Reeve; Sandra A Mitchell; Amylou C Dueck; Ethan Basch; David Cella; Carolyn Miller Reilly; Lori M Minasian; Andrea M Denicoff; Ann M O'Mara; Michael J Fisch; Cynthia Chauhan; Neil K Aaronson; Corneel Coens; Deborah Watkins Bruner
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

7.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

8.  Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.

Authors:  P Holch; L Warrington; L C A Bamforth; A Keding; L E Ziegler; K Absolom; C Hector; C Harley; O Johnson; G Hall; C Morris; G Velikova
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.